Left Kidney Undifferentiated Spindle Cell Sarcoma with Myeloid Cell Leukemia-1 Amplification: Therapeutic Response to Bortezomib, Venetoclax, and Dexamethasone Therapy

The overexpression of myeloid cell leukemia-1 (MCL-1) has been identified in numerous hematologic malignancies and solid tumors. Currently, there are no selective MCL-1 inhibitors. Here, we present a case of left kidney undifferentiated spindle cell sarcoma with MCL-1 amplification. The tumor showed...

Full description

Bibliographic Details

Published in:	Journal of Cancer Research and Practice
Main Authors:	Cheng-Yu Tang, Chueh-Chuan Yen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-10-01
Subjects:	bortezomib myeloid cell leukemia-1 amplification sarcoma venetoclax
Online Access:	https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00026